Saturday, July 11, 2026

pharma · Advanced Solid Tumor

LaNova Medicines

LaNova Medicines drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Shanghai, CN HQ
2019 Founded
15 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Shanghai, CN
Founded
2019
Employees
15
Programs
1
Drugs
0
Patents
0
Intelligence · Drug Pipeline

LaNova Medicines pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

LaNova Medicines drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →